Variable | PCI (n = 286) | CABG (n = 129) | MT (n = 296) | P value |
---|---|---|---|---|
Age (years) | 77.4 ± 2.5 | 76.8 ± 1.9 | 77.4 ± 2.5 | 0.029 |
Female | 92 (32.2) | 23 (17.8) | 89 (30.1) | 0.009 |
Body mass index (kg/m2) | 25.0 ± 3.0 | 25.1 ± 3.1 | 24.9 ± 3.0 | 0.352 |
Risk factors and comorbidities | Â | Â | Â | Â |
Hypertension | 203 (71.0) | 93 (72.1) | 212 (71.6) | 0.970 |
Diabetes mellitus | 103 (36.0) | 42 (32.6) | 107 (36.1) | 0.750 |
Previous myocardial infarction | 85 (29.7) | 50 (38.8) | 101 (34.1) | 0.176 |
Hyperlipidemia | 123 (43.0) | 60 (46.5) | 162 (54.7) | 0.016 |
Stroke | 38 (13.3) | 13 (10.1) | 42 (14.2) | 0.508 |
Peripheral artery disease | 13 (4.5) | 23 (17.8) | 28 (9.5) |  < 0.001 |
Chronic kidney disease | 2 (0.7) | 2 (1.6) | 11 (3.7) | 0.031 |
Smoker | 113 (39.5) | 56 (43.4) | 123 (41.6) | 0.738 |
Clinical presentation | Â | Â | Â | Â |
Stable angina pectoris | 81 (28.3) | 51 (39.5) | 80 (27.0) | 0.027 |
ACS | 205 (71.7) | 78 (60.5) | 216 (73.0) | 0.027 |
Left main disease | 57 (19.9) | 66 (51.2) | 104 (35.1) |  < 0.001 |
Left ventricular ejection fraction < 40% | 3 (1.0) | 2 (1.6) | 5 (1.7) | 0.797 |
Creatinine (μmol/L) | 89.7 ± 20.6 | 89.3 ± 17.8 | 92.5 ± 26.0 | 0.251 |
Creatinine clearance (ml/min) | 58.6 ± 14.6 | 60.4 ± 12.9 | 57.8 ± 16.3 | 0.256 |
SYNTAX score | Â | Â | Â | Â |
≤ 22 | 135 (47.2) | 20 (15.5) | 76 (25.7) |  < 0.001 |
23–32 | 103 (36.0) | 42 (32.6) | 108 (36.5) | 0.752 |
≥ 33 | 47 (16.4) | 67 (51.9) | 111 (37.5) |  < 0.001 |
Medication upon discharge | Â | Â | Â | Â |
Aspirin | 275 (96.2) | 119 (92.2) | 272 (91.9) | 0.082 |
Clopidogrel | 256 (89.5) | 11 (8.5) | 119 (40.2) |  < 0.001 |
Beta-blockers | 242 (84.6) | 103 (79.8) | 253 (85.5) | 0.329 |
Statins | 284 (99.3) | 128 (99.2) | 295 (99.7) | 0.781 |
Angiotensin converting enzyme inhibitors | 277 (96.9) | 126 (97.7) | 285 (96.3) | 0.743 |
Nitrates | 256 (89.5) | 117 (90.7) | 276 (93.2) | 0.271 |
Calcium channel blockers | 278 (97.2) | 126 (97.7) | 287(97.0) | 0.917 |